Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
620
archived clinical trials in
ADHD

A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/27/2014
Pediatric Psychopharmacology & Adult ADHD Program, Massachusetts General Hospital
mi
from
Boston, MA
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
Pediatric Psychopharmacology & Adult ADHD Program, Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/27/2014
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/27/2014
Behavioral Medicine Center
mi
from
Troy, MI
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
Behavioral Medicine Center
mi
from
Troy, MI
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/27/2014
St Charles Psychiatric Associates
mi
from
St. Charles, MO
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
St Charles Psychiatric Associates
mi
from
St. Charles, MO
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/27/2014
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/27/2014
Bioscience Research, Llc
mi
from
Mount Kisco, NY
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/27/2014
Duke University
mi
from
Durham, NC
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/27/2014
Richard H. Weisler, MD, PA
mi
from
Raleigh, NC
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
Richard H. Weisler, MD, PA
mi
from
Raleigh, NC
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/27/2014
Sequoia Behavioral Healthcare
mi
from
Media, PA
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
Sequoia Behavioral Healthcare
mi
from
Media, PA
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/27/2014
FutureResearch Trials
mi
from
Austin, TX
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
FutureResearch Trials
mi
from
Austin, TX
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/27/2014
FutureResearch Trials Dallas, LP
mi
from
Dallas, TX
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
FutureResearch Trials Dallas, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/27/2014
Bayou City Research, Ltd.
mi
from
Houston, TX
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
Bayou City Research, Ltd.
mi
from
Houston, TX
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/27/2014
NeuroScience, Inc. (NSI)
mi
from
Herndon, VA
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
NeuroScience, Inc. (NSI)
mi
from
Herndon, VA
Click here to add this to my saved trials
An Evaluation of Neurofeedback Efficacy in Adults With ADHD
A Placebo-Control Evaluation of Neurofeedback Efficacy in Adults With ADHD
Status: Enrolling
Updated:  6/17/2014
Department of Psychology, UNC Wilmington
mi
from
Wilmington, NC
An Evaluation of Neurofeedback Efficacy in Adults With ADHD
A Placebo-Control Evaluation of Neurofeedback Efficacy in Adults With ADHD
Status: Enrolling
Updated: 6/17/2014
Department of Psychology, UNC Wilmington
mi
from
Wilmington, NC
Click here to add this to my saved trials
Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging
Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging
Status: Enrolling
Updated:  9/19/2014
Massachusetts General Hospital
mi
from
Boston, MA
Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging
Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging
Status: Enrolling
Updated: 9/19/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
UCLA
mi
from
Los Angeles, CA
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Synergy Clinical Research
mi
from
National City, CA
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Synergy Clinical Research
mi
from
National City, CA
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Newport Beach Clinical Research Associates, Inc.
mi
from
Newport Beach, CA
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Newport Beach Clinical Research Associates, Inc.
mi
from
Newport Beach, CA
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Orange County Neuro Phychiatry Research Centre
mi
from
Orange, CA
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Orange County Neuro Phychiatry Research Centre
mi
from
Orange, CA
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Sarkis Clinical Research
mi
from
Gainesville, FL
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Sarkis Clinical Research
mi
from
Gainesville, FL
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Sarkis Clinical Trials
mi
from
Gainesville, FL
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Sarkis Clinical Trials
mi
from
Gainesville, FL
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
CNS Healthcare Jacksonville
mi
from
Jacksonville, FL
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
CNS Healthcare Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Florida Clinical Research Center
mi
from
Maitlin, FL
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Florida Clinical Research Center
mi
from
Maitlin, FL
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Miami Research Associates
mi
from
South Miami, FL
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Stedman Clinical Trials
mi
from
Tampa, FL
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Stedman Clinical Trials
mi
from
Tampa, FL
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Advanced Clinical Research
mi
from
Boise, ID
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Advanced Clinical Research
mi
from
Boise, ID
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Kennedy Krieger Institute
mi
from
Baltimore, MD
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Duke Univ Med Ctr
mi
from
Durham, NC
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
University of Cincinnati
mi
from
Cincinnati, OH
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
IPS Research Company
mi
from
Oklahoma City, OK
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
FutureSearch Clinical Trials LP
mi
from
Austin, TX
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
FutureSearch Clinical Trials LP
mi
from
Austin, TX
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Bayou City Research, Ltd.
mi
from
Houston, TX
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Bayou City Research, Ltd.
mi
from
Houston, TX
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Houston Clinical Trials, LLC
mi
from
Houston, TX
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Houston Clinical Trials, LLC
mi
from
Houston, TX
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Red Oak Psychiatry Associates, PA
mi
from
Houston, TX
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Red Oak Psychiatry Associates, PA
mi
from
Houston, TX
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Ericksen Research
mi
from
Clinton, UT
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Ericksen Research
mi
from
Clinton, UT
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Physiciatric and Behavioral Solutions
mi
from
Salt Lake City, UT
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Physiciatric and Behavioral Solutions
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
NeuroScience, Inc.
mi
from
Herndon, VA
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Northwest Clinical Research Center
mi
from
Bellvue, WA
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Northwest Clinical Research Center
mi
from
Bellvue, WA
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Eastside Therapeutic Resource
mi
from
Kirkland, WA
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Eastside Therapeutic Resource
mi
from
Kirkland, WA
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Mathison Centre for Mental Health Research and Education
mi
from
Calgary,
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Mathison Centre for Mental Health Research and Education
mi
from
Calgary,
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
UCLA
mi
from
Los Angeles, CA
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Synergy Clinical Research
mi
from
National City, CA
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Synergy Clinical Research
mi
from
National City, CA
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Newport Beach Clinical Research Associates, Inc.
mi
from
Newport Beach, CA
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Newport Beach Clinical Research Associates, Inc.
mi
from
Newport Beach, CA
Click here to add this to my saved trials